Bionomics Reports Topline Results in PREVAIL Phase 2 Study
BNC210 for Treatment of Social Anxiety Disorder (SAD) Did Not Meet Primary EndpointSubjects with Confirmed SAD who Received BNC210 Exhibited Trends Toward...
South Australia United States Kevin Gardner Spyridon Spyro Papapetropoulos Suzanne Irwin Connor Bernstein
Source: globenewswire.com